$CRL News
Last published 1d ago
- 1d agoCRLTigermed to Participate in the Privatization of Frontage Holdings Corporation and Divest Its Overseas Laboratory Services BusinessPR NewswireHangzhou Tigermed Consulting Co., Ltd. (Stock Codes: 300347.SZ / 3347.HK, hereinafter referred to as "Tigermed"), a leading global provider of...
- 2d agoCRLCharles River Laboratories to Acquire Frontage’s Bioanalysis and DMPK BusinessesBusiness WireWILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Acquire Frontage's Bioanalysis and DMPK Businesses
- 1w agoCRLQ3 2026 Charles River Laboratories International, Inc. Earnings Conference Call - CHARLES RIVER LABORATORIES INTERNATIONAL INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by. Welcome to the Charles River Laboratories third quarter 2026 earnings conference call. This conference call is being recorded. At this time, all participants are in a list
- 1w agoCRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 2w agoCRLCharles River Leverages Virtual Control Groups in GLP StudiesBusiness WireCollaboration highlights ongoing commitment to industry modernization and the highest animal welfare standards Charles River Laboratories International, Inc. (NYSE:CRL) today announced that its Virtual Control Group
- 2w agoCRLCharles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential AssessmentBusiness WireJoint research effort seeks to improve abuse potential assessment tools to support drug development and public health decision-making Charles River Laboratories International, Inc. (NYSE:CRL) today announced a
- 4w agoCRLCharles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine DevelopmentBusiness WireCollaboration leverages next-generation sequencing (NGS) services to advance development and commercialization of an off-the-shelf therapy for osteoarthritis and future programs Charles River Laboratories
- 1mo agoCRLCharles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference CallBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) will release third-quarter 2026 financial results on Wednesday, November 4th, before the market opens. A conference call has been scheduled to discuss this
- 1mo agoCRLCharles River and Autolomous Partner to Transform Laboratory Execution SystemsBusiness WirePartnership reinforces continued investment in digitization, automation, and client-facing transparency Charles River Laboratories International, Inc. (NYSE:CRL) and Autolomous today announced the launch of Apollo
- 1mo agoCRLCharles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor DayBusiness Wire– Outlines Pathway to Purpose Strategy to Modernize the Company, Strengthen Its Scientific Portfolio, and Enhance the Client Experience – – Issues Long-Term Financial Targets through 2030 – – Reaffirms 2026
- 1mo agoCRLCharles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking TimelinesBusiness WireCharles River platform offers 40% reduction in cell bank production timeline, over the industry standard of 20 weeks Charles River Laboratories International, Inc. (NYSE:CRL) has introduced rapid cell banking
- 1mo agoCRLBAIRD 2026 GLOBAL HEALTHCARE CONFERENCE - CHARLES RIVER LABORATORIES INTERNATIONAL INCEarnings Call TranscriptsOkay, good morning everyone. I'm Eric Coldwell. It's my pleasure to introduce Charles River. A little bit different. We've been on stage before. We'd been on stage before at a different company, but it's a little bitters
- 1mo agoCRLBAIRD 2026 GLOBAL HEALTHCARE CONFERENCE - CHARLES RIVER LABORATORIES INTERNATIONAL INCEarnings Call TranscriptsOkay, good morning everyone. I'm Eric Coldwell. It's my pleasure to introduce Charles River. A little bit different. We've been on stage before. We'd been on stage before at a different company, but it's a little bitters
- 1mo agoCRLMorgan Stanley 24th Annual Global Healthcare Conference - CHARLES RIVER LABORATORIES INTERNATIONAL INCEarnings Call TranscriptsPerfect. Good morning, everyone. Welcome to day one of Morgan Stanley's Global Healthcare Conference. I'm Callum Tishmarsh, the Life Sciences Analyst here at Morgan Stanley. Here today with the wonderful team from Charle
- 1mo agoCRLMorgan Stanley 24th Annual Global Healthcare Conference - CHARLES RIVER LABORATORIES INTERNATIONAL INCEarnings Call TranscriptsPerfect. Good morning, everyone. Welcome to day one of Morgan Stanley's Global Healthcare Conference. I'm Callum Tishmarsh, the Life Sciences Analyst here at Morgan Stanley. Here today with the wonderful team from Charle
- 1mo agoCRLMorgan Stanley 24th Annual Global Healthcare Conference - CHARLES RIVER LABORATORIES INTERNATIONAL INCEarnings Call TranscriptsPerfect. Good morning, everyone. Welcome to day one of Morgan Stanley's Global Healthcare Conference. I'm Callum Tishmarsh, the Life Sciences Analyst here at Morgan Stanley. Here today with the wonderful team from Charle
- 2mo agoCRLCharles River Laboratories to Present at Morgan Stanley and Baird ConferencesBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) announced today that it will present at two upcoming investor conferences, including: Morgan Stanley 24th Annual Global Healthcare Conference on Monday,
- 2mo agoCRLCharles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production SuiteBusiness WireEnhanced automation delivers improved traceability and capacity, while increasing manufacturing efficiency Charles River Laboratories International, Inc. (NYSE:CRL) has successfully implemented its Endosafe®
- 2mo agoCRLCharles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation SequencingBusiness WireCollaboration leverages NGS technologies to accelerate high-quality vaccine development, support global regulatory readiness, and help reduce animal testing Charles River Laboratories International, Inc. (NYSE:CRL)
- 3mo agoCRLCharles River Laboratories Announces Second-Quarter 2026 ResultsBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) today reported its results for the second quarter ended June 27, 2026. Key Highlights Reports second-quarter revenue of $1.00 billion, GAAP loss per share
- 3mo agoCRLCharles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference CallBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) will release second-quarter 2026 financial results on Wednesday, August 5th, before the market opens. A conference call has been scheduled to discuss this
- 4mo agoCRLCharles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment ApproachesBusiness WireCollaboration aligns with Charles River’s strategic commitment to building deeper client relationships and accelerating development with alternative methods Charles River Laboratories International, Inc. (NYSE:CRL)
- 4mo agoCRLCharles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing ExpertiseBusiness WireCollaboration supports Charles River's strategic goals to build deeper client relationships to further modernize R&D through innovative technologies Charles River Laboratories International, Inc. (NYSE:CRL)
- 5mo agoCRLCharles River Laboratories to Present at William Blair and Jefferies ConferencesBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) announced today that it will present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2nd, at 10:00 a.m. CT (11:00 a.m. ET), and at the
- 6mo agoCRLCharles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing SolutionsBusiness WirePartnership showcases a forward-looking collaboration model that highlights advanced testing expertise Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic,
- 6mo agoCRLCharles River Accelerates Digital Pathology with AI-Powered End-to-End WorkflowBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly accelerates study
- 6mo agoCRLCharles River Laboratories Announces First-Quarter 2026 ResultsBusiness Wire– Reports First-Quarter Revenue of $995.8 Million, GAAP Loss per Share of $(0.30), and Non-GAAP Earnings per Share of $2.06 – – Reaffirms 2026 Guidance for Organic Revenue and Non-GAAP Earnings per Share – –
- 6mo agoCRLCharles River Launches Rat In Vitro Fertility Services Demonstrating Embryology CapabilitiesBusiness WireAs the first commercial provider to deliver in vitro fertility services for rat models, Company demonstrates commitment to the 3Rs Charles River Laboratories today announced an enhanced In Vitro Fertility (IVF)
- 6mo agoCRLCharles River Highlights Effectiveness of VCGs in ToxicologyBusiness WirePeer-reviewed evidence supports the use of Virtual Control Groups in nonclinical toxicology studies Charles River Laboratories International, Inc. (NYSE:CRL) has shared the results of a retrospective analysis in
- 6mo agoCRLCharles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference CallBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) will release first-quarter 2026 financial results on Thursday, May 7th, before the market opens. A conference call has been scheduled to discuss this information
- 7mo agoCRLCharles River Advances Cardiovascular Health Awareness Through Support of the American Heart AssociationBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) today announced a collaboration with the American Heart Association, the world's leading nonprofit organization focused on heart and brain health, to support
- 7mo agoCRLNYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanXPR NewswireThe New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for ...
- 8mo agoCRLCharles River Laboratories to Present at TD Cowen and Barclays ConferencesBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) announced today that it will present at two upcoming investor conferences, including: TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, at
- 8mo agoCRLCharles River Laboratories Provides Update on Planned DivestituresBusiness Wire– Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets – – Updates 2026 Financial Guidance – Charles River Laboratories
- 8mo agoCRLCharles River Laboratories Announces Executive AppointmentsBusiness WireGlenn G. Coleman Will Join Charles River as Corporate Executive Vice President and Chief Financial Officer Kerry Dailey Will Join Charles River as Corporate Senior Vice President and Chief Legal Officer Charles
- 8mo agoCRLCharles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 GuidanceBusiness Wire– Fourth-Quarter Revenue of $994.2 Million and Full-Year Revenue of $4.02 Billion – – Fourth-Quarter GAAP Loss per Share of $(5.62) and Non-GAAP Earnings per Share of $2.39 – – Full-Year GAAP Loss per Share of
- 9mo agoCRLCharles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference CallBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) will release fourth-quarter and full-year 2025 financial results and provide 2026 guidance on Wednesday, February 18th, before the market opens. A conference
- 10mo agoCRLCharles River Laboratories Provides Business UpdatesBusiness Wire– Signs Agreement to Acquire K.F. (Cambodia) Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in 2026 and Approximately $0.60 in
- 10mo agoCRLCharles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession PlanBusiness Wire– Jim Foster, Chair, President & CEO, Announces Plans to Retire at the 2026 Annual Meeting of Shareholders in May 2026 After Distinguished 50-Year Career at Charles River – – Birgit Girshick, Current Executive
- 11mo agoCRLCharles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program CohortBusiness WireFinal 2025 global cohort onboarding, with applications now open for 2026 Charles River Laboratories International, Inc. (NYSE:CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program
- 11mo agoCRLCharles River Laboratories to Present at Evercore Healthcare ConferenceBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) announced today that it will present at the Evercore 8th Annual Healthcare Conference on Wednesday, December 3rd, at 10:00 a.m. ET. Management will provide an
- 11mo agoCRLCharles River Laboratories to Present at Jefferies Global Healthcare ConferenceBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) announced today that it will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 18th, at 11:30 a.m. GMT (6:30 a.m. ET).
- 1y agoCRLCharles River Laboratories Provides Update on Strategic ReviewBusiness Wire– Announces Steps to Strengthen and Refine Portfolio and to Maximize Financial Performance – Charles River Laboratories International, Inc. (NYSE:CRL) today announced an update on its Board of Directors' comprehensive
- 1y agoCRLCharles River Laboratories Announces Third-Quarter 2025 ResultsBusiness Wire– Third-Quarter Revenue of $1.00 Billion – – Third-Quarter GAAP Earnings per Share of $1.10 and Non-GAAP Earnings per Share of $2.43 – – Updates 2025 Guidance – Charles River Laboratories International, Inc.
- 1y agoCRLCharles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate DevelopmentBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and development, leveraging
- 1y agoCRLCharles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification CapabilitiesBusiness WireX-Chem's DNA-encoded library complements Charles River's discovery expertise to accelerate hit identification Charles River Laboratories International, Inc. (NYSE:CRL) today announced a strategic collaboration with
- 1y agoCRLCharles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and AdoptionBusiness WireCompany maintains focus on driving forward New Approach Methodologies to enhance safety and efficacy testing Charles River Laboratories International, Inc. (NYSE:CRL) today announced the creation of a global,
- 1y agoCRLCharles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference CallBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) will release third-quarter 2025 financial results on Wednesday, November 5th, before the market opens. A conference call has been scheduled to discuss this
- 1y agoCRLCharles River Laboratories Announces Chief Financial Officer TransitionBusiness Wire– Michael G. Knell, Corporate Senior Vice President & Chief Accounting Officer, Appointed Interim CFO by the Board of Directors – – Company Reaffirms 2025 Revenue and Non-GAAP EPS Guidance – Charles River
- 1y agoCRLCharles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat CancerBusiness WireCharles River Laboratories International, Inc. (NYSE:CRL) has recently announced two strategic collaborations across its contract development and manufacturing organization (CDMO), aimed at advancing novel oncology